Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo Rumi

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Journal of Medical Economics|April 27, 2026
Cost-effectiveness analysis of lorlatinib as first-line treatment for anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer in ItalyIlaria Valentini, Filippo Rumi, Eugenio Di Brino, et al.
Journal of Preventive Medicine and Hygiene|December 21, 2023
Feasibility study on a new enhanced device for patients with intermittent catheterization (LUJA)Giovanna Elisa Calabrò, Floriana D'Ambrosio, Francesca Orsini, et al.
International Journal of Technology Assessment in Health Care|March 2, 2023
The added value of applying a disinvestment approach to the process of health technology assessment in ItalyChiara Cadeddu, Luca Regazzi, Eugenio Di Brino, et al.
Drugs - Real World Outcomes|December 7, 2024
Determinants of the Financial Impact of Orphan Drugs in Italy: Differences Between Expected and Observed Pharmaceutical ExpenditureFrancesco Saverio Mennini, Americo Cicchetti, Paolo Sciattella, et al.
Global & Regional Health Technology Assessment|January 11, 2023
Filippo Rumi, Michele Basile, Americo Cicchetti, et al.
Journal of Medical Economics|April 11, 2023
Budget impact of prophylactic treatment of rVIII-SingleChain in moderate and severe hemophilia A in ItalyEugenio Di Brino, Songkai Yan, Radovan Tomic, et al.
Global & Regional Health Technology Assessment|February 11, 2026
Valentina Drago, Eugenio Di Brino, Roberta Laurita, et al.
Hepatobiliary Surgery and Nutrition|April 15, 2024
Evaluation of the economic impact of the robotic approach in major and postero-superior segment liver resections: a multicenter retrospective analysisSara Ingallinella, Francesco Ardito, Francesca Ratti, et al.
Frontiers in Gastroenterology (Lausanne, Switzerland)|March 13, 2026
A cost-of-illness study of eosinophilic esophagitis in Italy: assessing direct and indirect costsAgostino Fortunato, Debora Antonini, Edoardo Vincenzo Savarino, et al.
Plos Neglected Tropical Diseases|October 6, 2017
The cost-effectiveness of an eradication programme in the end game: Evidence from guinea worm diseaseChristopher Fitzpatrick, Dieudonné P Sankara, Junerlyn Farah Agua, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Journal of Medical Economics|April 27, 2026
Cost-effectiveness analysis of lorlatinib as first-line treatment for anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer in ItalyIlaria Valentini, Filippo Rumi, Eugenio Di Brino, et al.
Journal of Preventive Medicine and Hygiene|December 21, 2023
Feasibility study on a new enhanced device for patients with intermittent catheterization (LUJA)Giovanna Elisa Calabrò, Floriana D'Ambrosio, Francesca Orsini, et al.
International Journal of Technology Assessment in Health Care|March 2, 2023
The added value of applying a disinvestment approach to the process of health technology assessment in ItalyChiara Cadeddu, Luca Regazzi, Eugenio Di Brino, et al.
Drugs - Real World Outcomes|December 7, 2024
Determinants of the Financial Impact of Orphan Drugs in Italy: Differences Between Expected and Observed Pharmaceutical ExpenditureFrancesco Saverio Mennini, Americo Cicchetti, Paolo Sciattella, et al.
Global & Regional Health Technology Assessment|January 11, 2023
Filippo Rumi, Michele Basile, Americo Cicchetti, et al.
Journal of Medical Economics|April 11, 2023
Budget impact of prophylactic treatment of rVIII-SingleChain in moderate and severe hemophilia A in ItalyEugenio Di Brino, Songkai Yan, Radovan Tomic, et al.
Global & Regional Health Technology Assessment|February 11, 2026
Valentina Drago, Eugenio Di Brino, Roberta Laurita, et al.
Hepatobiliary Surgery and Nutrition|April 15, 2024
Evaluation of the economic impact of the robotic approach in major and postero-superior segment liver resections: a multicenter retrospective analysisSara Ingallinella, Francesco Ardito, Francesca Ratti, et al.
Frontiers in Gastroenterology (Lausanne, Switzerland)|March 13, 2026
A cost-of-illness study of eosinophilic esophagitis in Italy: assessing direct and indirect costsAgostino Fortunato, Debora Antonini, Edoardo Vincenzo Savarino, et al.
Plos Neglected Tropical Diseases|October 6, 2017
The cost-effectiveness of an eradication programme in the end game: Evidence from guinea worm diseaseChristopher Fitzpatrick, Dieudonné P Sankara, Junerlyn Farah Agua, et al.
Pageof 4